During the COVID-19 pandemic, many companies have been seeking an emergency use authorization (EUA) to push technologies onto the market that can help address the public health crisis. The EUA is granted when the benefits of the technology outweigh anticipated risks.
On May 21, regulatory experts Ed Dougherty, principal at Dougherty Consulting, and Peter Raymond, CEO of The New Bureau, will share their insights on how companies should be navigating the regulatory process with FDA, along with steps for implementing quality by design in crisis mode, and supply chain strategies for sourcing, manufacturing and distribution during the MedTech Intelligence Emergency Use Authorization Webinar. The event takes place from 1–2 pm ET. Don’t miss this opportunity to learn how your company can effectively push its product to the finish line. Register now!